The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation-Reference-Cited by-同舟云学术

The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation

Published:2011-05 Issue:5 Volume:52 Page:958-970
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Bolen Alyssa L.,Naren Anjaparavanda P.,Yarlagadda Sunitha,Beranova-Giorgianni Sarka,Chen Li,Norman Derek,Baker Daniel L.,Rowland Meng M.,Best Michael D.,Sano Takamitsu,Tsukahara Tamotsu,Liliom Karoly,Igarashi Yasuyuki,Tigyi Gabor

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference45 articles.

1. Aiming drug discovery at lysophosphatidic acid targets;Tigyi;Br. J. Pharmacol.,2010

2. The emerging role of lysophosphatidic acid in cancer;Mills;Nat. Rev. Cancer.,2003

3. Molecular mechanisms of lysophosphatidic acid action;Tigyi;Prog. Lipid Res.,2003

4. Lysophosphatidic acid synthesis and release;Pages;Prostaglandins Other Lipid Mediat.,2001

5. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid;Tsukahara;Mol. Cell.,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling;Molecules;2024-08-04

2. LPA-Induced Thromboxane A2-Mediated Vasoconstriction Is Limited to Poly-Unsaturated Molecular Species in Mouse Aortas;International Journal of Molecular Sciences;2024-06-22

3. TRPV1: Receptor structure, activation, modulation and role in neuro-immune interactions and pain;Cell Calcium;2024-05

4. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis;European Respiratory Review;2024-04-30

5. Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective Autotaxin inhibitor, in healthy subjects: A phase I randomized placebo-controlled trial;European Journal of Pharmaceutical Sciences;2023-10